Press Releases from Ophthalmology Drugs (3 total)
Worldwide Technology of Ophthalmology Drugs Market in Global Industry 2017
Albany, NY, 5th September : Recent research and the current scenario as well as future market potential of "Global Ophthalmology Drugs Market to 2023 - Angiogenesis Inhibitors in wAMD Set to Retain High Market Share, While Expansive Pipeline for Glaucoma Leads the Research Landscape" globally.
Ophthalmology is a broad therapy area that consists of almost 100 disorders associated with the eyes and visual system, including such diseases as glaucoma, age-related macular…
Global Ophthalmology Drugs Market to 2023 - Angiogenesis Inhibitors in wAMD Set …
Albany, NY, 1st September : Recent research and the current scenario as well as future market potential of " Global Ophthalmology Drugs Industry : Market Status, Size, Share, Trends and Application 2017 " globally.
Ophthalmology is a broad therapy area that consists of almost 100 disorders associated with the eyes and visual system, including such diseases as glaucoma, age-related macular degeneration (AMD), diabetic macular edema (DME), diabetic retinopathy (DR) and dry…
Rising Prevalence Of Lifestyle-Associated Disorders To Stimulate Uptake Of Ophth …
The report titled “Global Ophthalmology Drugs Market to 2022” presents a detailed evaluation of ophthalmology drugs related to five major disorders - diabetic macular edema, glaucoma, diabetic retinopathy, age-related macular degeneration (AMD), and dry eye syndrome. As per the findings of the report, the global ophthalmology market was valued at US$13.7 bn in 2015 and is estimated to reach US$26 bn by 2022, expanding at a CAGR of 9.48% from…
